|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-7-13
|
|
pubmed:abstractText |
Patients with non-Q-wave acute coronary syndromes (ACS) have substantial rates of recurrent ischemic events, but prognostic studies have been small or preceded the routine use of aggressive combination antithrombotic therapy. We sought to identify predictors of these events after antithrombotic treatment of non-Q-wave ACS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0002-8703
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
139
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
962-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10827375-Aged,
pubmed-meshheading:10827375-Angina, Unstable,
pubmed-meshheading:10827375-Aspirin,
pubmed-meshheading:10827375-Drug Administration Routes,
pubmed-meshheading:10827375-Drug Therapy, Combination,
pubmed-meshheading:10827375-Electrocardiography,
pubmed-meshheading:10827375-Enoxaparin,
pubmed-meshheading:10827375-Female,
pubmed-meshheading:10827375-Fibrinolytic Agents,
pubmed-meshheading:10827375-Heparin,
pubmed-meshheading:10827375-Humans,
pubmed-meshheading:10827375-Male,
pubmed-meshheading:10827375-Middle Aged,
pubmed-meshheading:10827375-Myocardial Ischemia,
pubmed-meshheading:10827375-Prognosis,
pubmed-meshheading:10827375-Recurrence,
pubmed-meshheading:10827375-Severity of Illness Index,
pubmed-meshheading:10827375-Survival Rate
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.
|
|
pubmed:affiliation |
Division of Cardiology, MCP-Hahnemann University School of Medicine, Philadelphia, PA 19102, USA. marc.cohen@tenethealth.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
